BIO-key ® International, Inc. (NASDAQ: BKYI), a leading provider of biometric enabled Identity and Access Management SaaS solutions for phoneless, tokenless, passwordless, and phish-resistant ...
The MarketWatch News Department was not involved in the creation of this content. COPENHAGEN, Denmark and HOLMDEL, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), ...
BIO-key® International, Inc. (NASDAQ: BKYI) shares were little changed Tuesday. The company, claiming to be a leading provider of biometric enabled Identity and Access Management SaaS solutions for ...
BIO-key reported a Q2’24 net loss of $1.7M compared to a Q2’23 net loss of $2.6M, primarily due to a $1M hardware reserve in Q2’23. Cash used in operating activities improved 48% to $1.1M in the first ...
BIO-key (BKYI) International announced a strategic partnership with Guinn Partners, a provider of advanced engineering solutions for robotics, drones, and electric propulsion systems. The companies ...
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report. BIO-key International is known for its Identity-Bound ...
The MarketWatch News Department was not involved in the creation of this content. HOLMDEL, N.J. and RIYADH, Saudi Arabia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), ...
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key ...
BIO-key (NASDAQ:BKYI) said it had received a continued listing deficiency notice from the Nasdaq because its share price had not met the $1.00 minimum closing bid price requirement for 30 consecutive ...
BIO-key International Inc., a developer of fingerprint identification solutions, announced Tuesday that it has appointed Barbara Rivera as chief operating officer.Rivera will be responsible for ...
FREMONT, CA - February 12, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company focusing on innovative treatments in ophthalmology, CNS (central ...
GRAPEVINE, Texas & HOLMDEL, N.J., Dec. 08, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results